Latest Blogs

May 05, 2021
Many years ago I treated a patient with a rare sarcoma. We recently reconnected and she generously shared her experience of being treated for and now considered "cured" of her rare tumor, with a reminder that the cancer experience is unique to every individual.
May 04, 2021
If luck, as Louis Pasteur noted, favors the prepared mind, how will oncologists not only prepare but extend cognitive capacity in an era where both medical knowledge and the scope of human endeavor that physicians must address continue to increase exponentially?
Apr 27, 2021
With the current pace of progress in cancer care, urgent implementation of cost-effectiveness training curriculum in fellowship training programs will be indispensable, shares Dr. Samer Al Hadidi. 
Apr 07, 2021
Educating ourselves about various religious customs and beliefs, in my opinion, is one way to promote inclusiveness. During Ramadan, you can help facilitate an inclusive culture at your institution in a few ways.
Subscribe to this column

International Perspectives

International Perspectives provides an interactive platform for international leaders in their respective fields to share perspectives on oncology topics. International Perspectives contributors are invited to post by invitation from ASCO’s volunteer leadership and key staff.

Feb 02, 2015
By Ian N. Olver, MD, PhD, FRACP. One-third of cancer deaths could be prevented by lifestyle choices alone. If there was a drug that claimed that success, it would be front page news. Changing behavior doesn’t seem dramatic, yet can be very difficult to achieve. The three areas in which the most...
Feb 02, 2015
By Sana Al Sukhun, MD, MSc, President of Jordan Oncology Society. Early detection has become the motto of public health campaigns all over the world. Not only does it reduce the burden of disease by reducing morbidity (complications of both disease and treatment), but also by reducing associated...
Feb 02, 2015
By Paul Ruff, MD, University of Witwatersrand, Johannesburg, South Africa. Since the turn of the century, we have seen a paradigm shift in the way we treat cancer, with the advent of targeted therapies, especially monoclonal antibodies and small molecule kinase inhibitors. Indeed the development of...
Nov 18, 2014
Tanja Cufer, MD, PhDASCO International Clinical Trials Workshop (ICTW) Working Group Chair    Dr. Tanja Cufer presents at the International Clinical Trials 
Jul 08, 2014
 By Nagi S. El Saghir, MD, FACPImmediate Past Chair, ASCO International Affairs CommitteeProfessor and Director, Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon

Pages